ABSTRACT
The investigation of the potential role of radiotherapy in rectal cancer was prompted by the unacceptable risk of local recurrence following conventional surgery when total excision of the mesorectum was not performed. This risk varied between 15% and 50% (1). In addition, when local recurrence occurred, it was associated with significant morbidity and was almost always fatal (1,2).
